OFFICE OF FISCAL ANALYSIS
Legislative Office Building, Room 5200
Hartford, CT 06106 (860) 240-0200
http://www.cga.ct.gov/ofa
sSB-186
AN ACT CONCERNING COLLABORATIVE DRUG THERAPY
MANAGEMENT AGREEMENTS AND POLICIES.
Primary Analyst: ME 3/28/22
Contributing Analyst(s): RDP
Reviewer: PR
OFA Fiscal Note
State Impact:
Agency Affected Fund-Effect FY 23 $ FY 24 $
Consumer Protection, Dept. GF - Cost 98,918 96,668
State Comptroller - Fringe
Benefits
1
GF - Cost 36,646 36,646
Note: GF=General Fund
Municipal Impact: None
Explanation
The bill allows the creation of collaborative drug therapy
management policies and agreements between prescribing practitioners
and pharmacists resulting in a cost to the Department of Consumer
Protection (DCP) and the Office of the State Comptroller. DCP will have
to hire one drug control agent for a total cost
2
of $135,564 in FY 23 and
$133,314 in FY 24 to review the collaborative drug therapy agreements
and enforce the expanded scope of practice for pharmacists.
The Out Years
The annualized ongoing fiscal impact identified above would
continue into the future subject to inflation.
1
The fringe benefit costs for most state employees are budgeted centrally in accounts
administered by the Comptroller. The estimated active employee fringe benefit cost
associated with most personnel changes is 40.53% of payroll in FY 23.
2
Total cost includes salary, other expenses, and fringe benefits.